Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study lays groundwork to develop new treatments for cardiovascular disease and other conditions

In a significant step toward restoring healthy blood circulation to treat a variety of diseases, a team of scientists at Weill Cornell Medical College has developed a new technique and described a novel mechanism for turning human embryonic and pluripotent stem cells into plentiful, functional endothelial cells, which are critical to the formation of blood vessels.

21 Jan 2010

Vivian and Seymour Milstein Family Heart Center to open to patients in February

Ushering in a new era in comprehensive cardiac care, the Vivian and Seymour Milstein Family Heart Center celebrated its opening today at NewYork-Presbyterian Hospital/Columbia University Medical Center.

21 Jan 2010

Sanofi-aventis U.S. brings national experts together to help aging Americans with AFib

National medical and lifestyle experts have been brought together by sanofi-aventis U.S. to help aging Americans learn to live life more fully despite a serious and increasingly prevalent heart condition – atrial fibrillation (AFib), a type of irregular heartbeat.

21 Jan 2010

VisEn Medical announces the commercial launch of new Cat B 680 FAST imaging agent

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 680 FAST™ imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo.

21 Jan 2010

Lantheus Medical Imaging announces the launch of ABLAVAR

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the launch of ABLAVAR™ (gadofosveset trisodium), a unique, injectable MRA imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD).

20 Jan 2010

Health Canada approves Novartis' Afinitor to treat patients with mRCC

Novartis Pharmaceuticals Canada Inc. (Novartis) announced today that Afinitor(R) (everolimus), a once-daily oral cancer treatment, has been approved by Health Canada for patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer, after failure of initial treatment with VEGF-receptor targeted therapies Sutent(R) (sunitinib) or Nexavar(R) (sorafenib).

20 Jan 2010

QuantRx Biomedical's developments in genetics-based technology

QuantRx® Biomedical Corporation, a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today provided an update from Chairman and Chief Executive Officer Walter Witoshkin on its involvement in genetics-based personalized medicine and disease prevention.

20 Jan 2010

Omega-3 fatty acids may protect against cellular aging in coronary heart disease patients

Patients with coronary heart disease who had higher omega-3 fatty acid blood levels had an associated lower rate of shortening of telomere length, a chromosome marker of biological aging, raising the possibility that these fatty acids may protect against cellular aging, according to a study in the January 20 issue of JAMA.

20 Jan 2010

LABEC Pharma meets European regulatory guidelines to sell Interleukin Genetics' Heart Health genetic test

Interleukin Genetics, Inc. and LABEC Pharma, S.L. announced today that LABEC Pharma has met European regulatory guidelines to sell Interleukin Genetics' Heart Health genetic test. The test, which helps to identify individuals at elevated risk for early heart attack, will be marketed to physicians in Spain and Portugal by LABEC Pharma under the product name Cardio Health™.

20 Jan 2010

Erectile dysfunction can be strongly related to the development of CVD

In the first study of its kind, New England Research Institutes, Inc. (NERI) in collaboration with the Division of Cardiology, San Francisco General Hospital and the University of California, San Francisco tested whether erectile dysfunction (ED) can be used to reclassify patients according to their future risk of developing cardiovascular disease (CVD) beyond traditional risk factors (such as smoking, high blood pressure, high cholesterol, etc).

20 Jan 2010

Combination treatment strategies may benefit patients with non-small cell lung cancer

Even when their tumors are shrinking in response to therapy, some non-small cell lung cancer (NSCLC) patients have a scattering of cancer cells that are undeterred by the drug, causing the tumor to resume its growth, Dana-Farber Cancer Institute and Massachusetts General Hospital (MGH) Cancer Center scientists report in the January issue of Cancer Cell.

20 Jan 2010

New issue from Annals of Internal Medicine

Prescriptions of some opioids, such as oxycodone, have increased significantly over the past decade. As long-term opioid therapy for chronic noncancer pain becomes more common, the deaths associated with opioids increase.

19 Jan 2010

CTO Summit features new developments in therapeutic procedures

The complete agenda for the Seventh International Chronic Total Occlusion (CTO) Summit is now available online at http://www.ctosummit.org/overview/agenda.html. The CTO Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions.

19 Jan 2010

"Nanoburrs" for treating cardiovascular diseases

Researchers at MIT and Harvard Medical School have built targeted nanoparticles that can cling to artery walls and slowly release medicine, an advance that potentially provides an alternative to drug-releasing stents in some patients with cardiovascular disease.

19 Jan 2010

High BMI among children and adolescents continues to be a public health concern in the U.S.

The prevalence of high weight for length or high body mass index (BMI) among children and teens in the U.S. (i.e., at or above the 95th percentile), ranges from approximately 10 percent for infants and toddlers, to approximately 18 percent for adolescents and teenagers, although these rates appear to have remained relatively stable over the past 10 years, except for an increase for 6- to 19-year-old boys who are at the very heaviest weight levels, according to a study appearing in the January 20 issue of JAMA. The study is being published early online because of its public health importance.

18 Jan 2010

Study shows key differences among Hispanic populations on the risk of cardiovascular disease

Latinos are not all the same when it comes to risk of heart disease, and a new study by a Columbia University researcher shows key differences among Hispanic populations that doctors should take into account in trying to stem the risk of cardiovascular disease in this large and growing subset of the U.S. population.

18 Jan 2010

Down syndrome and Alzheimer's disease are the same

Nearly 20 years ago Huntington Potter kicked up a storm of controversy with the idea that Down syndrome and Alzheimer's were the same disease. Now the evidence is in: He was right.

18 Jan 2010

ASA urges patients to make lifestyle changes before opting for complicated surgeries

At a time of year when people make plans to drop a few pounds, perhaps even consider bariatric surgery, the American Society of Anesthesiologists (ASA) wants to ensure the public has the facts regarding one's weight and the impact it may have on his or her anesthesia experience.

18 Jan 2010

Regulus Therapeutics presents new data on oncology, immune disease and HCV therapeutic programs

Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the “RNA Silencing: Mechanism, Biology and Application” Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.

18 Jan 2010

Fourth edition of IDF Diabetes Atlas reports high incidence of diabetes in developing countries

...

18 Jan 2010

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study lays groundwork to develop new treatments for cardiovascular disease and other conditions

Vivian and Seymour Milstein Family Heart Center to open to patients in February

Sanofi-aventis U.S. brings national experts together to help aging Americans with AFib

VisEn Medical announces the commercial launch of new Cat B 680 FAST imaging agent

Lantheus Medical Imaging announces the launch of ABLAVAR

Health Canada approves Novartis' Afinitor to treat patients with mRCC

QuantRx Biomedical's developments in genetics-based technology

Omega-3 fatty acids may protect against cellular aging in coronary heart disease patients

LABEC Pharma meets European regulatory guidelines to sell Interleukin Genetics' Heart Health genetic test

Erectile dysfunction can be strongly related to the development of CVD

Combination treatment strategies may benefit patients with non-small cell lung cancer

New issue from Annals of Internal Medicine

CTO Summit features new developments in therapeutic procedures

"Nanoburrs" for treating cardiovascular diseases

High BMI among children and adolescents continues to be a public health concern in the U.S.

Study shows key differences among Hispanic populations on the risk of cardiovascular disease

Down syndrome and Alzheimer's disease are the same

ASA urges patients to make lifestyle changes before opting for complicated surgeries

Regulus Therapeutics presents new data on oncology, immune disease and HCV therapeutic programs

Fourth edition of IDF Diabetes Atlas reports high incidence of diabetes in developing countries

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in